Dr. Marder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
130 Rampart Way
Ste 300B
Denver, CO 80230Phone+1 303-327-4700Fax+1 303-327-4711
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Nephrology, 2000 - 2003
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1997 - 2000
Tel Aviv University SacklerClass of 1997
Certifications & Licensure
CO State Medical License 2003 - 2025
ND State Medical License 2019 - 2020
NY State Medical License 1998 - 2003
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012
Publications & Presentations
PubMed
- 16 citationsEffect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus.Didier A. Mandelbrot, J. Alberu, A. Barama, B. A. Marder, Helio Tedesco Silva
American Journal of Transplantation. 2015-12-01 - 13 citationsOpen-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients.Helio Tedesco-Silva, V. Ram Peddi, Ana Sánchez-Fructuoso, Brad A. Marder, Graeme R. Russ
Transplantation Direct. 2016-03-03 - 1 citationsTreatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression.V Ram Peddi, Bradley Marder, Luis Gaite, Jose Oberholzer, Ryan Goldberg
Transplantation Direct. 2023-02-01
Other Languages
- Spanish, Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
